Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2007-03-12 13:20:14 UTC
Update Date2022-03-07 02:49:29 UTC
HMDB IDHMDB0005814
Secondary Accession Numbers
  • HMDB05814
Metabolite Identification
Common NameTestosterone enanthate
DescriptionTestosterone enanthate is used in androgen substitution to replace testosterone at levels as close to physiological levels as is possible. For some androgen-dependent functions testosterone is a pro-hormone, peripherally converted to 5alpha-dihydrotestosterone (DHT) and 17beta-estradiol (E2), of which the levels preferably should be within normal physiological ranges. Furthermore, androgens should have a good safety profile without adverse effects on the prostate, serum lipids, liver or respiratory function, and they must be convenient to use and patient-friendly, with a relative independence from medical services. Natural testosterone is viewed as the best androgen for substitution in hypogonadal men. testosterone enanthate is used to treat male hypogonadism. Male hypogonadism is one of the most common endocrinologic syndromes. The diagnosis is based on clinical signs and symptoms plus laboratory confirmation via the measurement of low morning testosterone levels on two different occasions. Serum luteinizing hormone and follicle-stimulating hormone levels distinguish between primary (hypergonadotropic) and secondary (hypogonadotropic) hypogonadism. Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism. In primary hypogonadal men the on bone mineral density (BMD) responds dose dependently to testosterone substitution, whereas in secondary hypogonadism only testosterone enanthate treatment significantly increased the BMD. In all mammalian species studied to date, testosterone has been found to be the predominant intratesticular steroid. In volunteers receiving hormonal contraception by using a combination of testosterone enanthate and levonorgestrel, there is a profound reduction of both intratesticular testosterone concentration and androgen bioactivity. High doses of testosterone enanthate can normalize hematocrit values of maintenance hemodialysis patients with replenished bone marrow iron stores. testosterone enanthate is classified as a prohibited substance by the World Anti-Doping Agency (WADA) and its use may be detected by way of the urinary testosterone/epitestosterone (T/E) ratio. (PMID: 16185098 , 16467270 , 15329035 , 17530941 , 17484401 , 4028529 , 12792150 ).
Structure
Data?1582752366
Synonyms
ValueSource
17-((1-Oxoheptyl)oxy)androst-4-en-3-oneChEBI
17-Hydroxyandrost-4-en-3-one, 17-heptanoateChEBI
17beta-Hydroxyandrost-4-en-3-one heptanoateChEBI
Testosterone 17-enanthateChEBI
Testosterone heptanoateChEBI
DelatestrylKegg
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acidGenerator
17b-Hydroxyandrost-4-en-3-one heptanoateGenerator
17b-Hydroxyandrost-4-en-3-one heptanoic acidGenerator
17beta-Hydroxyandrost-4-en-3-one heptanoic acidGenerator
17Β-hydroxyandrost-4-en-3-one heptanoateGenerator
17Β-hydroxyandrost-4-en-3-one heptanoic acidGenerator
Testosterone 17-enanthic acidGenerator
Testosterone heptanoic acidGenerator
Testosterone enanthic acidGenerator
17beta-Enanthoxyandrost-4-en-3-oneHMDB
17beta-Hydroxyandrost-4-en-3-one enanthateHMDB
4-Androsten-17beta-ol-3-one 17-enanthateHMDB
4-Androsten-3-one 17beta-enanthateHMDB
Androgyn l.a.HMDB
AndropositoryHMDB
AndrotardylHMDB
AtlatestHMDB
DEA no. 4000HMDB
DelatestHMDB
DePatestryeHMDB
depo-testro MedHMDB
DitateHMDB
DurathateHMDB
EveroneHMDB
Exten testHMDB
Malogen l.a.HMDB
Malogen l.a.200HMDB
Orquisteron-eHMDB
PrimotestoneHMDB
reposo TMDHMDB
TestanthateHMDB
TestateHMDB
TestenateHMDB
TestinonHMDB
TestoenantHMDB
TestonenantHMDB
Testosterone 17beta-heptanoateHMDB
Testosterone 17beta-heptanoic acidHMDB
Testosterone enantateHMDB
Testosterone heptoateHMDB
Testosterone heptoic acidHMDB
Testosterone heptylateHMDB
Testosterone oenanthateHMDB
TestostrovalHMDB
BTG Brand OF testosterone enanthateMeSH, HMDB
Jenapharm brand OF testosterone enanthateMeSH, HMDB
Rotexmedica brand OF testosterone enanthateMeSH, HMDB
Testosteron-depot jenapharmMeSH, HMDB
Pasadena brand OF testosterone enanthateMeSH, HMDB
Primoteston depotMeSH, HMDB
Rugby brand OF testosterone enanthateMeSH, HMDB
Testosteron depot-rotexmedicaMeSH, HMDB
Testosteron-depot eifelfangoMeSH, HMDB
Testrin p.a.MeSH, HMDB
Roberts brand OF testosterone enanthateMeSH, HMDB
eifelfango Brand OF testosterone enanthateMeSH, HMDB
Schering brand OF testosterone enanthateMeSH, HMDB
Theramed brand OF testosterone enanthateMeSH, HMDB
TheramexMeSH, HMDB
Chemical FormulaC26H40O3
Average Molecular Weight400.594
Monoisotopic Molecular Weight400.297745146
IUPAC Name(1S,2R,10R,11S,14S,15S)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-14-yl heptanoate
Traditional Nameeverone
CAS Registry Number315-37-7
SMILES
[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
InChI Identifier
InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1
InChI KeyVOCBWIIFXDYGNZ-IXKNJLPQSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassSteroids and steroid derivatives
Sub ClassSteroid esters
Direct ParentSteroid esters
Alternative Parents
Substituents
  • Steroid ester
  • Androgen-skeleton
  • Androstane-skeleton
  • 3-oxosteroid
  • 3-oxo-delta-4-steroid
  • Oxosteroid
  • Delta-4-steroid
  • Cyclohexenone
  • Ketone
  • Carboxylic acid ester
  • Cyclic ketone
  • Monocarboxylic acid or derivatives
  • Carboxylic acid derivative
  • Organooxygen compound
  • Carbonyl group
  • Organic oxide
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Aliphatic homopolycyclic compound
Molecular FrameworkAliphatic homopolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
Process
Role
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting Point36 - 37.5 °CNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.00046 g/LALOGPS
logP5.11ALOGPS
logP6.29ChemAxon
logS-5.9ALOGPS
pKa (Strongest Acidic)19.09ChemAxon
pKa (Strongest Basic)-4.8ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area43.37 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity116.61 m³·mol⁻¹ChemAxon
Polarizability49.2 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+200.23131661259
DarkChem[M-H]-196.05631661259
DeepCCS[M-2H]-235.91230932474
DeepCCS[M+Na]+212.13430932474
AllCCS[M+H]+206.032859911
AllCCS[M+H-H2O]+204.132859911
AllCCS[M+NH4]+207.732859911
AllCCS[M+Na]+208.232859911
AllCCS[M-H]-193.932859911
AllCCS[M+Na-2H]-195.232859911
AllCCS[M+HCOO]-196.932859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Testosterone enanthate[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C4098.5Standard polar33892256
Testosterone enanthate[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C3235.5Standard non polar33892256
Testosterone enanthate[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C3333.1Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Testosterone enanthate,1TMS,isomer #1CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C3242.8Semi standard non polar33892256
Testosterone enanthate,1TMS,isomer #1CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C3195.3Standard non polar33892256
Testosterone enanthate,1TMS,isomer #1CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C3723.4Standard polar33892256
Testosterone enanthate,1TBDMS,isomer #1CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C3492.8Semi standard non polar33892256
Testosterone enanthate,1TBDMS,isomer #1CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C3398.7Standard non polar33892256
Testosterone enanthate,1TBDMS,isomer #1CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(O[Si](C)(C)C(C)(C)C)=CC[C@]4(C)[C@H]3CC[C@]12C3843.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Testosterone enanthate GC-MS (Non-derivatized) - 70eV, Positivesplash10-00dr-3479000000-622103246e9253c3578f2017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Testosterone enanthate GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Testosterone enanthate GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Testosterone enanthate 10V, Positive-QTOFsplash10-0udi-2594800000-2fe5b98ade2c6812e2902017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Testosterone enanthate 20V, Positive-QTOFsplash10-022i-5592000000-689f1cdb34f31cd98d152017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Testosterone enanthate 40V, Positive-QTOFsplash10-05mo-4490000000-d66a654ef39db2b122652017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Testosterone enanthate 10V, Negative-QTOFsplash10-0002-0149000000-2bec5293e6f91f7dbff52017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Testosterone enanthate 20V, Negative-QTOFsplash10-000i-0393000000-1dfe91f6ac9835af89282017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Testosterone enanthate 40V, Negative-QTOFsplash10-0a4r-2190000000-387672165ae5773ca45b2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Testosterone enanthate 10V, Negative-QTOFsplash10-0002-0109000000-867f88cb280a910aabe92021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Testosterone enanthate 20V, Negative-QTOFsplash10-01r2-1926000000-bc6e667c95b200d2ea912021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Testosterone enanthate 40V, Negative-QTOFsplash10-0a4l-9101000000-86eb2f6d2ad8f02878cd2021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Testosterone enanthate 10V, Positive-QTOFsplash10-0udi-0040900000-fe6a5cf79e52e56acc462021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Testosterone enanthate 20V, Positive-QTOFsplash10-0229-1981100000-256658d507dc1dea45172021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Testosterone enanthate 40V, Positive-QTOFsplash10-06r6-5920000000-9787c0613d8215ab200b2021-09-25Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Extracellular
  • Membrane
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDBSALT001030
Phenol Explorer Compound IDNot Available
FooDB IDFDB023772
KNApSAcK IDNot Available
Chemspider ID9045
KEGG Compound IDC08157
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkTestosterone enanthate
METLIN IDNot Available
PubChem Compound9416
PDB IDNot Available
ChEBI ID9464
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceUlrich, Miroslav; Novacek, Alois; Stejskal, Frantisek. Testosterone enanthate. (1960), CS 95825 19600615 CAN 55:81895 AN 1961:81895
Material Safety Data Sheet (MSDS)Download (PDF)
General References
  1. Jarow JP, Zirkin BR: The androgen microenvironment of the human testis and hormonal control of spermatogenesis. Ann N Y Acad Sci. 2005 Dec;1061:208-20. [PubMed:16467270 ]
  2. Darby E, Anawalt BD: Male hypogonadism : an update on diagnosis and treatment. Treat Endocrinol. 2005;4(5):293-309. [PubMed:16185098 ]
  3. Gooren LJ, Bunck MC: Androgen replacement therapy: present and future. Drugs. 2004;64(17):1861-91. [PubMed:15329035 ]
  4. Rogerson S, Weatherby RP, Deakin GB, Meir RA, Coutts RA, Zhou S, Marshall-Gradisnik SM: The effect of short-term use of testosterone enanthate on muscular strength and power in healthy young men. J Strength Cond Res. 2007 May;21(2):354-61. [PubMed:17530941 ]
  5. Giuberti A, Manganini V, Picozzi SC, Vigano P, Strada GR: Complete genital prosthetization in patients treated with bilateral orchiectomy for metachronous testicular cancer. Arch Ital Urol Androl. 2007 Mar;79(1):26-9. [PubMed:17484401 ]
  6. Schustack A, Meshiaj D, Waiss Z, Gotloib L: Intramuscular iron replenishment and replacement combined with testosterone enanthate in maintenance hemodialysis anemia: a follow-up of up to 8 years on 16 patients. Clin Nephrol. 1985 Jun;23(6):303-6. [PubMed:4028529 ]
  7. Schubert M, Bullmann C, Minnemann T, Reiners C, Krone W, Jockenhovel F: Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism. Horm Res. 2003;60(1):21-8. [PubMed:12792150 ]